top of page

EFFecT members at Synergistic Meeting on Oligonucleotide Therapeutics (SMOT) in Valencia (27 & 28 February)

March 1st 2025

​

​​

​

​

Six members of EFFecT participated in the Synergistic Meeting on Oligonucleotide Therapeutics (SMOT) in Vaencia (Spain) on February 27th and 28th (rare disease day). ​

​

Our consortium members presented their own research, chaired sessions or pitched initiatives. Also EFFecT MSCA DN was officially presented. 

​

Remember, the application period for 12 fully funded PhD positions closes on March 15! The description of the different projects and profiles are provided in Euraxess.

EFFecT wishes you Happy Holidays!

December 23rd 2024

​

​​

​

​

EFFecT wishes you all a great Holiday Season and all the best wishes for 2025!​

​

Our consortium will officially kick off on January 1st and between July and October all Doctoral Candidates (DC) will be hired. 

​

Description of the different projects and profiles are provided in Euraxess. Application is now open. Please make sure to read the instructions, as some partners require double application. 

​

Wishing you a healthy and successful 2025!

EFFecT announcement

December 3rd 2024

​

First project descriptions are available in the PhD Project section. â€‹

​

Description of the vacancies and profiles will be published soon in Euraxess. We will share the link on this website!

​

Stay tuned!

EFFecT on the media

October 24th 2024

​

 

News in English:

https://webmagazine.unitn.it/en/news/cibio/122413/effect-european-commission-kicks-off-doctoral-training-network-on-antisense 

​

​https://www.cbm.uam.es/index.php/2024/10/22/training-the-next-generation-of-scientists-in-antisense-technology/

​

https://www.radboudumc.nl/en/news-items/2024/three-european-msca-dn-grants-for-research-at-radboudumc

​

https://cordis.europa.eu/project/id/101168372

​

News in Dutch:

https://www.radboudumc.nl/nieuws/2024/drie-europese-msca-dn-subsidies-voor-onderzoek-van-het-radboudumc

 

https://zorgkrant.nl/wetenschap-en-onderwijs/18908-radboud-umc-heeft-drie-europese-msca-dn-subsidies-voor-onderzoek-gekregen

​

https://www.lumc.nl/actueel/2024/prijzen-subsidies-en-benoemingen-2-oktober/

​

News in Spanish:

https://www.uam.es/uam/noticias/red-effect-terapias-antisentido-2024

 

https://www.cbm.uam.es/index.php/2024/10/22/formando-a-la-proxima-generacion-de-cientificos-en-terapias-antisentido/?lang=es

​

https://www.bio-bizkaia.eus/en/-/el-grupo-nat-rd-de-biobizkaia-participa-en-la-red-doctoral-effect-para-formar-a-los-futuros-expertos-en-terapias-antisentido?redirect=%2Fhome

​

News in French:

https://www.uvsq.fr/financement-europeen-pour-lequipe-daurelie-goyenvalle

​

News in Italian:

https://www.quotidianosanita.it/provincia_autonoma_trento/articolo.php?articolo_id=125381

​​

​https://webmagazine.unitn.it/news/cibio/122412/effect-la-commissione-europea-d-il-via-a-una-rete-di-formazione-dottorale-sulle

​

Young Investigator Award for Hélène Tran

October 9th 2024

 

Hélène Tran has been awarded with the 2024 Mary Ann Liebert, Inc. publishers Young Investigator Award during the Oligonucleotide Therapeutics Society Annual Meeting!

 

Congratulations Hélène!

​

This prestigious award recognizes the contribution to the field of young investigators (up to 15 years post-PhD). More information about the award can be found here: 

Young Investigator Award - Oligonucleotide Therapeutics Society

We are live!

October 8th 2024

 

The EFFecT website has been released! More information will be updated in the coming months!

Stay tuned!

Contact

HORIZON-MSCA-2023-DN — EFFecT  — No.101168372

bottom of page